We have received a copy of an amendment to the September 2006 voluntary License Agreement between Gilead Sciences, Inc and Ranbaxy Laboratories, Ltd concerning the manufacture and sale of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine for the treatment of HIV-AIDS.
On Tuesday, 20 May 2008, the United Arab Emirates, Nigeria, Ghana, Gambia and Tunisia introduced a draft resolution (A61/A/Conf. Paper No 1) on counterfeiting.
While counterfeiting medicines is an important public health problem, and as traditionally defined, is a criminal enterprise that should be subject to tough legal sanctions, the resolution is problematic.
On April 15, 2008, WIPO released its long awaited Report on the International Patent System. Continue Reading
In a blog posted today on the Huffington Post, I could have, should have, elaborated a bit on the few U.S. journalists who had written about the trade disputes involving patents on medicines, before AIDS activists began their zaps of Gore’s presidential campaign in June of 1999.
Friday, 25 January 2008
The GWU-KEI workshop on the Medical Innovation Prize Fund will be a one-day meeting held on February 8, 2008 at the Law School of George Washington University (GWU), co-sponsored by GWU Law School and Knowledge Ecology International (KEI). The workshop will be open to the public and with no fee to attend.
Tom Giovanetti kindly sent me a link to his latest NGO bashing. This one titled: “IP skeptic NGOs as Marxists.” This is his attempt to label the various public health groups as Marxists, and his brief attempt to understand or describe a February 2005 proposal for one possible approach R&D Treaty.
First, I have told Tom Giovanetti several times that while his hysterical red baiting is amusing at times, it is also sometimes offensive and boring.
Agenda for the Maastricht Meeting on Medical Innovation Prizes
Official Website for the Meeting on Medical Innovation Prizes
KEI / UNU-MERIT Prize for the Best Paper on Monetary Prizes to Stimulare Medical R&D
The following are selected cables from the US Department of State, obtained under the U.S. FOIA statutes, concerning patents and price negotiations on AIDS drugs. 2004 U.S. DoS Cable: GOB REACHES PRICING AGREEMENTS ON THREE MORE AIDS DRUGS – January… Continue Reading
Tuesday, 07 August 2007
Contacts:
Lawyers Collective: Anand Grover: +91.9820184788; Chan Park: + 91.9899452377
Continue Reading